Haluatko tehdä tarjouksia julkisista hankinnoista? Tutustu TaaS-tarjousvalmistelupalveluumme
Tarjouskilpailut

Myyntiluvattomat lääkkeet

Avoin
Määräaika
13 päivää jäljellä
Huhtikuu 29, 2026
Sopimuksen tiedot
Kategoria
Tarvikkeet
Viite
304813
Arvo
€449,770
Sijainti
Estonia, Viro
Julkaistu
Maaliskuu 18, 2026
CPV-koodi
Arviointikriteerit
Total cost of the medicinal product with the active substance iloprost100%
Total cost of the medicinal product with the active substance naloksegool100%
Total cost of the medicinal product with the active substance activated charcoal100%
Total cost of the medicinal product with the active substance rifaximin100%
Total cost of the medicinal product with the active substance fidaxomicin100%
Total cost of the medicinal product with the active substance cholecalciferol100%
Total cost of the medicinal product with the active substance thiamine100%
Total cost of the medicinal product with the active substance pyridoxine100%
Total cost of the medicinal product with the active substance potassium chloride100%
Total cost of the medicinal product with the active substance phosphates100%
Total cost of the medicinal product with the active substance papaverine hydrochloride100%
Total cost of the medicinal product with the active substance bisacodyl100%
Projektin aikataulu

Tarjouskilpailu julkaistu

Maaliskuu 18, 2026

Kysymysten jättämisen määräaika

Huhtikuu 22, 2026

Tarjousten jättämisen määräaika

Huhtikuu 29, 2026

Tarjousten avaaminen

Huhtikuu 20, 2026

VoittotodennäköisyysPRO
🔒
Päivitä Professional-tasolle
Näe arvioitu voittotodennäköisyytesi historiallisen datan perusteella.
Päivitä ammattilaiseksi →
Ostajan tiedusteluPRO
🔒
Avaa ostajan tiedustelu
Näe kulutusmallit, suositellut menettelyt ja paljon muuta.
Päivitä ammattilaiseksi →
Toimialan näkemyksetPRO
🔒
Avaa toimialan näkemykset
Näe keskimääräiset voittajahinnat, kilpailutasot ja markkinatrendit.
Päivitä ammattilaiseksi →
Budjetti
€449,770
Kesto
Ei määritelty
Sijainti
Estonia
Tyyppi
Tarvikkeet
75
Laatupisteet/100
Hyvä
Markkinoiden vertailu
Keskim. voittajahinta
€92,792
Keskim. tarjoukset
2.2
Kilpailu
Matala
PK-yritys voittajat
86%
3,220 analysoitua tarjouskilpailua

Alkuperäinen tarjouskilpailun kuvaus

Myyntiluvattomien lääkkeiden hankinta
Sähköinen jättö

Suorita riskianalyysi

Tunnista mahdolliset riskit, epäjohdonmukaisuudet ja varoitusmerkit kaikista tarjousasiakirjoista. Saat yksityiskohtaisen riskiraportin, jossa on vakavuustasot ja lievennyssuositukset.

Kirjaudu sisään

Voittostrategia

Tekoälypohjainen analyysi tämän tarjouskilpailun vaatimuksista, mahdollisuuksista ja haasteista. Saat strategisia näkemyksiä voittomahdollisuuksiesi maksimoimiseksi.

70%
Arvioitu voittomahdollisuusKohtalainen sopivuus

This tender is heavily weighted towards cost, making aggressive pricing the primary driver for success. Bidders must ensure meticulous cost calculation and demonstrate compliance with all mandatory requirements, particularly regarding the exclusion of Russian Federation-linked entities. While social value and innovation are absent, operational efficiency and supply chain reliability are implicit.

Keskeiset voittoviestit

Unbeatable Price, Uncompromised Quality: Delivering essential medicines at the lowest possible cost while ensuring full marketing authorization and adherence to technical specifications.

Reliable Supply Chain, Russian Federation-Free: Guaranteeing a secure and compliant supply of critical medications with a commitment to a supply chain free from undue Russian Federation influence.

Keskeiset mahdollisuudet
Aggressive pricing strategy to capture the 100% cost-based evaluation.
Leveraging existing long-term supply agreements for cost optimization.
Demonstrating a robust and verifiable supply chain free from Russian Federation ties.
Streamlining the bid submission process for accuracy and speed.
Keskeiset haasteet
Intense price competition due to 100% cost weighting.

Conduct thorough cost analysis, explore all avenues for cost reduction (e.g., bulk purchasing, optimized logistics), and consider offering slightly lower margins if strategically viable to win the entire contract.

Ensuring absolute compliance with the Russian Federation supplier restriction.

Conduct a comprehensive audit of all current and potential subcontractors and suppliers. Obtain written declarations from all key partners confirming their non-affiliation or minimal (under 10%) affiliation with the Russian Federation. Maintain detailed records to support this claim.

Potential for errors in the detailed Excel submission ('304813 Tehniline ettepanek ühikuhinnad').

Implement a rigorous internal review process for the Excel table. Utilize multiple team members for data entry and verification, cross-referencing with product catalogs and pricing sheets. Consider using data validation tools within Excel.

Ihanteellinen tarjoajaprofiili
A well-established pharmaceutical distributor or manufacturer with a strong, cost-competitive supply chain for generic and essential medicines. The ideal bidder will have robust internal cost management systems, a proven track record of reliable delivery, and a clear understanding of the Estonian pharmaceutical market. They must also be able to demonstrate a supply chain free from significant Russian Federation influence.
Keskeiset vaatimukset
Confirmation of acceptance of tender document conditions.
Submission of completed application for participation.
Accurate completion of the '304813 Tehniline ettepanek ühikuhinnad' Excel table.
Confirmation of no more than 10% involvement of subcontractors/suppliers related to the Russian Federation.
Medicinal products must have marketing authorization and meet technical specifications (dosage, packaging).
Definition of business secrets.
Submission of power of attorney for joint offers.
Submission of ESPD_v2.0_laiendatud.xml (implied by format mention).
Keskeiset erottuvuustekijät
The most competitive unit pricing across all listed active substances, demonstrating exceptional cost management and supply chain efficiency.
A demonstrably robust and transparent supply chain with clear evidence of compliance with the Russian Federation supplier restriction.
Exceptional accuracy and completeness in the bid submission, particularly the detailed Excel table, minimizing any administrative issues.
Sosiaalisen arvon mahdollisuudet
While not explicitly required, a bidder could proactively mention their commitment to ethical sourcing and fair labor practices within their supply chain, even if not a formal evaluation criterion. This can be a subtle differentiator.
Tarjouksen painopisteet
Total cost of the medicinal product with the active substance naloksegool100.0%

Achieve the absolute lowest unit price through optimized sourcing and efficient logistics. Ensure this price is accurately reflected in the Excel table.

Total cost of the medicinal product with the active substance activated charcoal100.0%

Aggressively price this item to be the lowest. Leverage any available volume discounts or direct manufacturer relationships.

Total cost of the medicinal product with the active substance papaverine hydrochloride100.0%

Focus on securing the most competitive pricing, potentially through alternative sourcing if direct supply is expensive.

Total cost of the medicinal product with the active substance bisacodyl100.0%

Ensure this is among the lowest bids. Explore generic or off-patent options if applicable and compliant.

Total cost of the medicinal product with the active substance rifaximin100.0%

Prioritize cost leadership. If this is a high-volume item, even small savings per unit can be significant.

Total cost of the medicinal product with the active substance fidaxomicin100.0%

Aim for the lowest possible price. Research current market prices and supplier capabilities.

Total cost of the medicinal product with the active substance cholecalciferol100.0%

Secure the lowest unit price. This is often a widely available and competitive item.

Total cost of the medicinal product with the active substance thiamine100.0%

Focus on aggressive pricing. Consider bulk purchasing if possible.

Total cost of the medicinal product with the active substance pyridoxine100.0%

Ensure competitive pricing. This is a common vitamin, so expect high competition.

Total cost of the medicinal product with the active substance potassium chloride100.0%

Achieve the lowest price. This is a basic electrolyte, likely with many suppliers.

Total cost of the medicinal product with the active substance phosphates100.0%

Target the lowest price. Similar to potassium chloride, expect competitive sourcing.

Total cost of the medicinal product with the active substance iloprost100.0%

Aggressively price this item. If it's a specialized medication, ensure reliable sourcing at a competitive rate.

Suositukset6
Ruthless Cost Optimization and Aggressive Pricing
KriittinenKorkea vaiva

Given the 100% cost weighting for each active substance, the primary focus must be on achieving the absolute lowest possible unit price for every item. This requires a deep dive into supply chain costs, logistics, and potential for economies of scale. Consider offering a slightly lower margin than usual if it guarantees winning the entire contract.

Directly maximizes score in the sole evaluation criterion, significantly increasing win probability.
Meticulous Compliance with Russian Federation Supplier Restriction
KriittinenKorkea vaiva

Thoroughly audit all subcontractors and suppliers to ensure no more than 10% of the contract value is linked to the Russian Federation. Obtain written confirmations and maintain detailed records. Failure to comply will lead to disqualification.

Ensures eligibility and avoids immediate disqualification.
Flawless Excel Table Submission
KriittinenKeskitason vaiva

The '304813 Tehniline ettepanek ühikuhinnad' Excel table is a critical submission document. Implement a multi-stage review process involving at least two individuals to verify data accuracy, unit prices, and total costs against source documents. Ensure all required columns are populated correctly.

Prevents administrative errors that could lead to disqualification or scoring penalties.
Demonstrate Supply Chain Reliability and Security
KorkeaKeskitason vaiva

While not explicitly asked for, implicitly, the contracting authority needs reliable delivery. Highlight your company's track record for on-time delivery, inventory management, and contingency planning for supply disruptions. This can be a subtle differentiator if competitors only focus on price.

Builds confidence in the bidder's ability to fulfill the contract, potentially influencing decisions in case of very close bids.
Accurate ESPD Submission
KeskitasoKeskitason vaiva

Ensure the ESPD_v2.0_laiendatud.xml file is correctly generated and submitted if required. Pay close attention to the file format mentioned, as it's flagged as not supported for AI analysis, suggesting a specific manual or system requirement.

Ensures the bid is formally accepted and processed correctly.
Clarify Ambiguities Early
KeskitasoMatala vaiva

If any aspect of the tender documents, particularly regarding the Excel format or the Russian Federation restriction, is unclear, submit a formal clarification request to the contracting authority well before the deadline. This demonstrates diligence and ensures accurate compliance.

Reduces the risk of misinterpretation and potential disqualification.
Kilpailuasema
Position as the most cost-effective provider without compromising on the quality and authorization of medicinal products. Emphasize a lean operational model and efficient supply chain that enables these low prices. Highlight the robust compliance with the Russian Federation supplier restriction as a sign of responsible and ethical business practices.

Kilpailijat

Päivitä nähdäksesi, mitkä yritykset todennäköisesti tekevät tarjouksen tästä hankinnasta, perustuen historialliseen hankintadataan.

Kirjaudu sisään

Vaatimukset ja pätevyydet

13 vaatimusta 5 kategoriassa

Jättäminen (4)
Pakollinen (1)
Vaatimustenmukaisuus (4)
Tekninen (2)
Taloudellinen (2)
SUBMISSION REQUIREMENTS4
--A completed application for participation in the procurement procedure must be submitted.
--An Excel table titled "304813 Tehniline ettepanek ühikuhinnad" must be submitted with detailed information on medicinal products (ATC code, active substance, dosage form, unit price, total cost).
--The bidder must confirm that no more than 10% of subcontractors or suppliers related to the Russian Federation will be involved in the performance of the contract.
MANDATORY EXCLUSION GROUNDS1
--None explicitly stated.
ELIGIBILITY REQUIREMENTS4
--Bidders must confirm acceptance of tender document conditions.
--Bidders must account for all costs of the bid.
--For joint offers, a power of attorney must be submitted.
TECHNICAL CAPABILITY REQUIREMENTS2
--The supplier must provide medicinal products with marketing authorization.
--The medicinal products must meet the specific requirements detailed in the technical specification, including certain dosage forms and packaging.
FINANCIAL REQUIREMENTS2
--The total value of the tender is 449770.0 EUR.
--Bids will be evaluated based on cost, with the lowest price receiving maximum points.

Vaatimusten esikatselu

Rekisteröidy nähdäksesi täydelliset vaatimukset ja analyysin

Asiakirjat

8 asiakirjaa saatavilla AI-yhteenvedoilla

VastavustingimusedPDF
304813_vastavustingimused.pdf -- 491.7 KB

The bidder must confirm that no more than 10% of the contract value will involve subcontractors or suppliers linked to the Russian Federation, and if it's a joint bid, provide a power of attorney and define trade secrets.

Pakkuja esitab täidetud hankemenetluses osalemise avalduseDOC
304654 Hankemenetluses osalemise avaldus.docx -- 50.7 KB

The bidder must submit a completed application to participate in the procurement procedure, confirming agreement with the tender document conditions and consideration of all bid costs.

Pakkuja esitab täidetud tabeli "304813 Tehniline ettepanek ühikuhinnad"XLS
304813 Tehniline ettepanek ühikuhinnad.xlsx -- 34.8 KB

Bidders must submit a completed table "304813 Technical Proposal Unit Prices" detailing information on medicines, including ATC code, active substance, dosage form, unit price, and total cost.

Hindamiskriteeriumid ja hinnatavad näitajadPDF
304813_hindamiskriteeriumid.pdf -- 147.4 KB

The tender evaluates the cost of bids, where the lowest price receives the maximum score, and is submitted in an Excel table.

Hankepass täiendatavate selgitustegaPDF
304813_hankepass_taiendavate_selgitustega.pdf -- 81.9 KB

The Procurement Pass is an initial self-declaration by the economic operator, containing the conditions set by the contracting authority and expected responses, but is not intended for completion.

Lepingu projekt osad 1, 12, 24-27, 37, 40, 47, 49, 50, 54, 55, 68, 74DOC
304813 Apteegikauba riigihanke raamleping_osa... -- 32.7 KB

This document contains the draft framework agreement for the public procurement of pharmacy goods, governing the supply and sale of medicines to North Estonia Medical Centre.

osad Lepingu projekt osad 2-11, 13-23, 28-36, 38, 39, 41-46, 48, 51-53, 56-67, 6...DOC
304813 Apteegikauba riigihanke raamleping_osa... -- 55.1 KB

This document contains the draft framework agreement for the public procurement of pharmacy goods for parts 2-11, 13-23, 28-36, 38, 39, 41-46, 48, 51-53, 56-67, 69-73, defining the agreement's purpose, object, and validity.

Tehniline kirjeldusXLS
304813 Tehniline kirjeldus.xlsx -- 28.7 KB

The contracting authority North Estonia Medical Centre is seeking medicinal products with marketing authorization that meet the specific requirements outlined in the technical description, including particular dosage forms and packaging.

Asiakirjojen esikatselu

Rekisteröidy nähdäksesi asiakirjojen yhteenvedot ja analyysin

75
Hyvä

Hankinnan laatupisteet

This tender for the purchase of authorized medicinal products is generally well-structured with clear requirements and a reasonable timeline. However, it lacks explicit evaluation criteria beyond price and has limited sustainability considerations.

Pisteiden erittely

Lainsäädännön noudattaminen75/100

The tender appears to comply with general procurement regulations, including the provision of a CPV code and a clear procedure. Deadlines are reasonable, and the estimated value is disclosed. No disputes are noted. The requirement regarding subcontractors linked to the Russian Federation is a specific compliance point that needs careful monitoring.

Selkeys80/100

The description of the procurement is clear ('Müügiloata ravimite ostmine' - Purchase of authorized medicinal products). Requirements for technical capability and submission are detailed. However, the absence of explicit evaluation criteria beyond price could lead to ambiguity in the selection process.

Missing explicit evaluation criteria beyond price.
Täydellisyys70/100

Most basic information is present, including the estimated value, duration (implied by tender validity), and organization. Key documents like the application form and technical proposal table are specified as required. However, the contract duration is not explicitly stated, and some contract parts are marked as not required, which could be a point of confusion.

Contract duration not explicitly stated.
Some contract parts marked as not required.
Reiluus85/100

The tender promotes fairness through e-submission and e-procurement. Objective criteria for technical capability are implied through the need for marketing authorization and meeting technical specifications. The price-based evaluation is clear. The requirement concerning subcontractors linked to the Russian Federation, while potentially a geopolitical consideration, could be perceived as a constraint if not carefully justified and applied universally.

Requirement regarding subcontractors linked to the Russian Federation could be perceived as a constraint.
Käytännöllisyys65/100

E-submission is mandated, and a URL for the opening place is provided. Financing information is not explicitly detailed, and the contract start date is not specified. The duration of the contract is also missing, impacting long-term planning for bidders.

Financing information not explicitly detailed.
Contract start date not specified.
Tietojen yhdenmukaisuus90/100

Key fields such as title, reference, organization, estimated value, and deadlines are populated. There are no noted suspensions or disputes. Dates appear logical within the context of the tender timeline.

Kestävyys50/100

There is no explicit mention of green procurement, social aspects, or innovation. The tender is not indicated as EU funded. This suggests a lack of focus on sustainability criteria.

No green procurement criteria.
No social criteria.

Vahvuudet

Clear description of goods to be procured.
Mandatory e-submission and e-procurement.
Reasonable submission deadline.
Detailed technical and submission requirements.

Huolenaiheet

Lack of explicit evaluation criteria beyond price.
Absence of sustainability considerations (green, social, innovation).
Missing contract duration and start date.

Suositukset

1. Specify detailed evaluation criteria beyond just price.
2. Incorporate sustainability aspects into the tender requirements.
3. Clarify contract duration and start date.

Tekoälyn pisteytyksen esikatselu

Rekisteröidy nähdäksesi täydelliset vaatimukset ja analyysin

Täydellinen laatupisteanalyysi
Yksityiskohtainen osapisteiden erittely
Vahvuudet ja huolenaiheet -näkemykset
Strategiset suositukset

Luottokorttia ei vaadita • Asennus 2 minuutissa

Lisää prosessiin